Literature DB >> 28570862

Monocyte inflammatory profile is specific for individuals and associated with altered blood lipid levels.

Vyoma K Patel1, Helen Williams1, Stephen C H Li2, John P Fletcher1, Heather J Medbury3.   

Abstract

BACKGROUND AND AIMS: Atherogenesis is dependent upon monocyte influx into the vessel wall. In humans, three monocyte subsets exist, the number and function of which are significantly altered in cardiovascular disease (CVD). Whether such alterations arise in individuals with a perturbed lipid profile remains largely unanswered, but is important to delineate, as adoption of a pro-inflammatory state may promote plaque formation. Here, we compared the inflammatory status of monocyte subsets and determined whether monocyte inflammatory changes are evident in individuals with a perturbed lipid profile.
METHODS: Monocyte subset cytokine production, inflammatory and anti-inflammatory marker expression were determined by whole blood flow cytometry and related to participants' lipid levels.
RESULTS: The intermediate and non-classical monocytes were more inflammatory than classicals as seen by their higher cytokine production (TNF-α, IL-1β, IL-6) and M1 marker (CD86) expression, but lower levels of M2 markers (CD93, CD163). More importantly, a considerable variation was seen between participants, with all monocytes of one individual being more inflammatory than those of another. Many inter-individual differences were related to participants' lipid levels. IL-1β production correlated negatively with Apo A1 and HDL-C. CD86 and TLR2 correlated positively with Chol:HDL-C but negatively with HDL-C and Apo A1:Apo B. Interestingly, CD163 expression correlated positively with Chol:HDL-C but negatively with Apo A1:Apo B.
CONCLUSIONS: Our data indicates that priming of all monocytes to an inflammatory state occurs in individuals with a perturbed lipid profile, overriding the normal functional distinction attributed to the different monocyte subsets. As such, all monocytes may be important in CVD.
Copyright © 2017 The Authors. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Atherosclerosis; Individual differences; Inflammation; Lipids; Monocyte subsets

Mesh:

Substances:

Year:  2017        PMID: 28570862     DOI: 10.1016/j.atherosclerosis.2017.05.026

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  20 in total

Review 1.  HIV Latency in Myeloid Cells: Challenges for a Cure.

Authors:  Alisha Chitrakar; Marta Sanz; Sanjay B Maggirwar; Natalia Soriano-Sarabia
Journal:  Pathogens       Date:  2022-05-24

2.  LDL associates with pro-inflammatory monocyte subset differentiation and increases in chemokine receptor profile expression in African Americans.

Authors:  Cristhian A Gutierrez-Huerta; Briana S Turner; Sophie E Claudel; Nicole Farmer; Rafique Islam; Valerie M Mitchell; Billy S Collins; Yvonne Baumer; Alan T Remaley; Tiffany M Powell-Wiley
Journal:  Int J Cardiol       Date:  2022-04-15       Impact factor: 4.039

3.  Ligation of Na, K ATPase β3 subunit on monocytes by a specific monoclonal antibody mediates T cell hypofunction.

Authors:  Nuchjira Takheaw; Witida Laopajon; Sirirat Surinkaew; Saichit Khummuang; Supansa Pata; Watchara Kasinrerk
Journal:  PLoS One       Date:  2018-06-25       Impact factor: 3.240

4.  Characterization of Human Monocyte Subsets by Whole Blood Flow Cytometry Analysis.

Authors:  Rekha Marimuthu; Habib Francis; Suat Dervish; Stephen C H Li; Heather Medbury; Helen Williams
Journal:  J Vis Exp       Date:  2018-10-17       Impact factor: 1.355

5.  Contribution of the uremic milieu to an increased pro-inflammatory monocytic phenotype in chronic kidney disease.

Authors:  Natalia Borges Bonan; Eva Schepers; Roberto Pecoits-Filho; Annemieke Dhondt; Anneleen Pletinck; Filip De Somer; Raymond Vanholder; Wim Van Biesen; Andréa Moreno-Amaral; Griet Glorieux
Journal:  Sci Rep       Date:  2019-07-15       Impact factor: 4.379

6.  A Novel, Five-Marker Alternative to CD16-CD14 Gating to Identify the Three Human Monocyte Subsets.

Authors:  Siew-Min Ong; Karen Teng; Evan Newell; Hao Chen; Jinmiao Chen; Thomas Loy; Tsin-Wen Yeo; Katja Fink; Siew-Cheng Wong
Journal:  Front Immunol       Date:  2019-07-26       Impact factor: 7.561

7.  Bovine HDL and Dual Domain HDL-Mimetic Peptides Inhibit Tumor Development in Mice.

Authors:  Feng Su; Anantharamaiah Gm; Mayakonda N Palgunachari; C Roger White; Holly Stessman; Yanyuan Wu; Jay Vadgama; Richard Pietras; Dorothy Nguyen; Srinivasa T Reddy; Robin Farias-Eisner
Journal:  J Cancer Res Ther Oncol       Date:  2020-01-17

8.  Association of serum lipids and severity of epithelial ovarian cancer: an observational cohort study of 349 Chinese patients.

Authors:  Yi Zhang; Jing Wu; Jun-Ya Liang; Xing Huang; Lei Xia; Da-Wei Ma; Xin-Yu Xu; Ping-Ping Wu
Journal:  J Biomed Res       Date:  2018-09-29

9.  Identification of Novel Human Monocyte Subsets and Evidence for Phenotypic Groups Defined by Interindividual Variations of Expression of Adhesion Molecules.

Authors:  F Merah-Mourah; S O Cohen; D Charron; N Mooney; A Haziot
Journal:  Sci Rep       Date:  2020-03-10       Impact factor: 4.379

10.  Altered monocytic phenotypes are linked with systemic inflammation and may be linked to mortality in dialysis patients.

Authors:  Sabine Brandt; Lara Ewert; Florian G Scurt; Charlotte Reichardt; Jonathan A Lindquist; Xenia Gorny; Berend Isermann; Peter R Mertens
Journal:  Sci Rep       Date:  2019-12-13       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.